CClinicalTrials.gg
Status unknownNCT04977102Updated Jul 26, 2021

A Randomized Study of Intraocular Caliper-assisted Capsulotomy for Age-related Cataract Patients With Corneal Limbus Opacity

An interventional study of Intraocular caliper-assisted capsulotomy and Verion navigation system-assisted capsulotomy in Cataract Extraction, sponsored by Zhongshan Ophthalmic Center, Sun Yat-sen University. Status unknown at 1 site in China. Open to participants aged 55 Years to 80 Years. Per ClinicalTrials.gov, last updated 2021-07-26.

Sponsored by Zhongshan Ophthalmic Center, Sun Yat-sen University · Not applicable, Interventional, and Other

The sponsor has not verified this record recently (last verified Jul 2021), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
74
Allocation
Randomized
Ages
55 Years to 80 Years
Sex
All
01

Study summary

The purpose of this study is to compare the accuracy of capsulotomy assisted by intraocular caliper and Verion navigation system in phacoemulsification surgery and postoperative visual quality for age-related cataract patients with corneal limbus opacity.

Read the detailed description

Continuous curvilinear capsulorhexis (CCC) is an important and technically challenging procedure in cataract surgery. Too large or too small capsulorhexis can increase the incidence of intraoperative and postoperative complications.

In recent years, the image projection device Verion navigation system has been reported that it can improve the repeatability and accuracy of capsulorhexis via projecting a pre-set size ring to guide capsulorhexis. However, we found that for the patients with corneal geriatric ring, pterygium or limbal lesions leading to unclear limbal boundary, the projected capsulorhexis will deviate from the center, resulting in capsulorhexis is off center in clinical practice. Our self-developed intraocular caliper, which is modified on the conventional intraocular irrigation needle, can accurately measure the size of capsulorhexis, and mark the position and boundary of capsulorhexis on the lens anterior capsule to guide capsulorhexis, thus significantly improves the accuracy and centricity of capsulorhexis.

The purpose of this study is to compare the centricity and accuracy of intraocular caliper-assisted capsulorhexis in phacoemulsification for age-related cataract patients with corneal limbus opacity with that of Verion projection navigation system.

02

Conditions studied

  • Cataract Extraction

Browse trials for

03

In context

Cataract

1,701 studies on the registry are indexed under Cataract; 230 are open to participants now.

This study's planned enrollment of 74 is close to the median of 80 across 1,155 interventional studies indexed under Cataract.

Browse Cataract studies →

Lead sponsor

Zhongshan Ophthalmic Center, Sun Yat-sen University is the lead sponsor of 159 studies on the registry; 77 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
55 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adults aged 55 to 80 years with age-related cataract with pterygium, Corneal geriatric ring, and corneal limbus opacity;
  • Pupil diameter ≥ 6.5mm after pupil dilation;
  • Lens nuclear opacity grading score (LOCS III) lower than 4.0.

Exclusion criteria

Exclusion Criteria:

  • Patients had previous intraocular surgery;
  • Patients with a diagnosed eye disease that may affect the functions of lens suspensory ligament such as previous ocular trauma, lens subluxation, pseudoexfoliation syndrome, retinal pigment degeneration;
  • Patients had other ocular diseases that impair visual function include optic neuropathy, uveitis, and tumor.
  • Refused to participate the study.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
74 participants (estimated)

Study arms

  • Experimental
    Intraocular caliper-assisted capsulotomy group

    In intraocular caliper-assisted capsulotomy group, a modified intraocular caliper with standard calibration on the rinse needle was used to measure and locate the position of capsulorhexis with 5.3 mm diameter and the principle of pupillary margin in concentric circles. The surgeon could gently use the blunt needle in the front of the intraocular caliper to further make corresponding markers on the lens anterior capsule, and then carry out capsulotomy according to the marks.

    Procedure: Intraocular caliper-assisted capsulotomy

  • Active comparator
    Verion navigation system-assisted capsulotomy group

    In the Verion-assisted capsulotomy group, Verion navigation system was applied to project a 5.3 mm capsulorhexis centered on the corneal vertex. According to the projected capsulorhexis, capsulotomy was performed.

    Procedure: Verion navigation system-assisted capsulotomy

Interventions

  • ProcedureIntraocular caliper-assisted capsulotomy

    Intraocular caliper is a modified intraocular caliper with standard calibration on the rinse needle.

  • ProcedureVerion navigation system-assisted capsulotomy

    Verion Image Guided System (Alcon Laboratories, Inc.) is a digital image guidance system consisting of a diagnostic reference unit and a surgery pilot for intraoperative surgical assistance. The device can be used to align toric intraocular lens during surgery as well as support manual creation of a capsulorhexis with a predefined target diameter.

06

What researchers measure

Primary outcomes

  1. Distance between pupil center and capsulorhexis center

    The primary outcome was the distance between pupil center and capsulorhexis center. Clear images of the edges of IOL and capsulorhexis were taken at the end of the operation, and Image J image analysis software is used to measure the distance between pupil center and capsulorhexis center with the diameter of IOL optical surface (6 mm) as the reference by two independently professional graders at the meantime.

    Time frame: During the surgery

Secondary outcomes

  1. Uncorrected and corrected visual acuity

    Evaluated with ETDRS visual acuity chart.

    Time frame: One month after surgery

  2. Ideal ratio of capsulorhexis

    Ideal capsulorhexis is defined as a centered and round capsulorhexis , which can cover the edge of IOL optical surface continuously for 360 degrees with a diameter between 5.0 to 5.5 mm.

    Time frame: During the surgery

  3. Grades of capsulorhexis-IOL overlap

    The capsulorhexis-IOL overlap of each patient was graded as 360-degree continuous overlap, 270\~360-degree overlap, 180\~270-degree overlap, 90\~180-degree overlap, and \< 90-degree overlap.

    Time frame: During the surgery

  4. Deviation of horizontal and vertical diameter of capsulorhexis from the target diameter (5.3 mm)

    Measured by Image J image analysis software.

    Time frame: During the surgery

  5. Horizontal and vertical diameter of capsulorhexis

    Measured by Image J image analysis software.

    Time frame: During the surgery

  6. Intraocular lens tilt

    Measured by anterior segment OCT (CASIA2).

    Time frame: One month after surgery

  7. Intraocular lens decentration

    Measured by anterior segment OCT (CASIA2).

    Time frame: One month after surgery

  8. Intraocular aberrations

    Measured by OPD-SCAN III.

    Time frame: One month after surgery

  9. Distance between pupil center and capsulorhexis center

    Time frame: One month after surgery

07

Study locations

1 site
  • Zhongshan Ophthalmic Center, Sun Yat-sen University
    Guangzhou, 510060, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 26, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04977102
Lead sponsor
Zhongshan Ophthalmic Center, Sun Yat-sen University
Responsible party
Sponsor
First posted
Jul 26, 2021
Start date
Aug 1, 2021 (estimated)
Primary completion
Jul 31, 2022 (estimated)
Completion
Oct 31, 2022 (estimated)
Last update
Jul 26, 2021

Study contacts

Xiaoyun Chen, PhD
Contact
chenxiaoyun@gzzoc.com
+86 13632343642

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion